Hepatitis B virus X protein protects against anti-Fas-mediated apoptosis in human liver cells by inducing NF-κB

Journal of General Virology

Volumn 82, Issue 1, 2001, Pages 171-182

  Pan, J ^a   Duan, L X ^a   Sun, B S ^a   Feitelson, M A ^a  

^a THOMAS JEFFERSON UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

FAS ANTIBODY; FAS LIGAND; HEPATITIS B ANTIGEN; I KAPPA B; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; MESSENGER RNA; RECEPTOR; VIRUS PROTEIN;

APOPTOSIS; ARTICLE; CANCER GROWTH; CELL KILLING; CELL PROTECTION; CELL SURVIVAL; CONTROLLED STUDY; GENETIC TRANSFECTION; HEPATITIS B; HEPATITIS B VIRUS; HEPATOMA CELL; HUMAN; HUMAN CELL; IMMUNE RESPONSE; LIVER CARCINOGENESIS; LIVER CELL; PATHOGENESIS; PRIORITY JOURNAL; VIRUS REPLICATION;

DNA VIRUSES; HEPATITIS B VIRUS;

EID: 0035155733     PISSN: 00221317     EISSN: None     Source Type: Journal    
DOI: 10.1099/0022-1317-82-1-171     Document Type: Article

References (79)

1. Class I-restricted cytotoxic T lymphocytes are directly cytopathic for their target cells
2. Nuclear factor-κB/Rel blocks transforming growth factor β1-induced apoptosis of murine hepatocyte cell lines
3. The inducible transcription activator NF-κB: Regulation by distinct protein subunits
4. Full-length and truncated versions of the hepatitis B virus (HBV) X protein (pX) transactivate the c-myc protooncogene at the transcriptional level
5. An essential role for NF-κB in preventing TNF-α-induced cell death
6. Embryonic lethality and liver degeneration in mice lacking the RelA component of NF-κB
7. Inhibition of NF-κB activity induces apoptosis in murine hepatocytes
8. HBV HBx protein deregulates cell cycle checkpoint controls
9. Hepatitis B virus pX activates NF-κB dependent transcription through a Raf-independent pathway
10. Transcriptional activation of homologous and heterologous genes by the HBV X gene product in cells permissive for viral replication
11. Hepatitis B X-gene expression in hepatocellular carcinoma
12. The hepatitis B virus HBx protein is a dual specificity cytoplasmic activator of Ras and nuclear activator of transcription factors
13. Intracellular immunization against HIV-1 infection of human T lymphocytes: Utility of anti-Rev single-chain variable fragments
14. NF-kappaB regulates Fas/APO-1/CD95- and TCR-mediated apoptosis of T lymphocytes
15. Hepatitis B virus X protein and p53 tumor suppressor interactions in the modulation of apoptosis
16. Hepatitis B virus x antigen in the pathogenesis of chronic infections and the development of hepatocellular carcinoma
17. Characteristics of woodchuck hepatitis X antigen in the livers and sera from chronically infected animals
18. HBxAg and p53 are associated in vitro and in liver tissues from patients with primary hepatocellular carcinoma
19. Abrogation of negative growth regulatory pathways by hepatitis B virus encoded X antigen in the development of hepatocellular carcinoma
20. CD95-induced apoptosis in human liver disease
21. Involvement of the Apo-1/Fas (CD95) receptor and ligand in liver damage
22. Recombinant genomes which express chloramphenicol acetyltransferase in mammalian cells
23. The hepatitis B virus HBx protein inhibits caspase 3 activity
24. NF-κB and Rel: Participants in a multiform transcriptional regulatory system
25. Characterization of an immediate-early gene induced in adherent monocytes that encodes IκB-like activity
26. Hepatitis B virus transcriptional activators: Mechanisms and possible role in oncogenesis
27. Malignant transformation of immortalized hepatocytes by hepatitis B virus DNA
28. Regulation of fasligand expression during activation-induced cell death in T lymphocytes via nuclear factor kappaB
29. HBV transactivator HBx uses a tumour promoter signalling pathway
30. HBx gene of HBV induces liver cancer in transgenic mice
31. X-gene induces apoptosis in liver cells
32. High-level expression of hepatitis B virus HBx gene and hepatocarcinogenesis in transgenic mice
33. Apoptosis and viral hepatitis
34. HBV X protein interacts with a probable cellular DNA repair protein
35. The human hepatitis B virus transactivator X gene product regulates Sp1 mediated transcription of an insulin-like growth factor II promoter 4
36. Severe liver degeneration in mice lacking the IκB kinase 2 gene
37. The translation initiation factor, SUI1, may be a target of hepatitis B x antigen in hepatocarcinogenesis
38. NF-kappaB functions as both a proapoptotic and antiapoptotic regulatory factor within a single cell type
39. Regulation of the NF-κB/rel transcription factor and IκB inhibitor system
40. Dissection of TNF receptor I effector function: JNK activation is not linked to apoptosis while NF-κB activation prevents cell death
41. Hepatitis B virus X protein transactivates human interleukin-8 gene through acting on nuclear factor κB and CCAAT enhancer binding protein-like cis-elements
42. Hepatitis C virus core protein inhibits Fas- and tumor necrosis factor alpha-mediated apoptosis via NF-kappaB activation
43. Signal transduction through NF-κB
44. Trans-activation of epidermal growth factor receptor gene by the hepatitis B virus X-gene product
45. Redesign of retrovirus packaging cell line to avoid recombination leading to helper virus formation
46. Improved retroviral vectors for gene transfer and expression
47. Fas antigen expression in liver tissues of patients with chronic hepatitis B
48. Differential target cell sensitivity to CTL-activated death pathways in hepatitis B virus transgenic mice
49. Effect of X protein on transactivation of HBV promoters and on viral replication
50. Induction of the DNA-binding activity of c-Jun/c-Fos heterodimers by the hepatitis B virus transactivator pX
51. Ras- and Raf-dependant activation of c-jun transcriptional activity by the hepatitis B virus transactivator pX
52. Lethal effect of the anti-Fas antibody in mice
53. Selective accumulation of the X transcript of hepatitis B virus in patients negative for hepatitis B surface antigen with hepatocellular carcinoma
54. Morphological and biochemical criteria of apoptosis
55. Fas-dependent apoptosis is impaired by SV40-T antigen in transgenic liver
56. 2+-independent T cell-mediated cytotoxicity
57. In vitro tumorigenicity of hepatitis B virus DNA and HBx protein
58. Production of hepatitis B virus particles in HepG2 cells transfected with cloned hepatitis B virus DNA
59. Replicative intermediates of hepatitis B virus in HepG2 cells that produce infectious virions
60. Expression of fas ligand in human hepatoma cell lines: Role of hepatitis B virus (HBX) in induction of Fas ligand
61. The X gene of hepatitis B virus induced growth stimulation and tumorigenic transformation of mouse NIH3T3 cells
62. Trans-activation of viral enhancer including the long terminal repeat of HIV by the HBV X protein
63. Lymphocyte apoptosis induced by CD95 (APO-1/Fas) ligand expressing tumor cells - A mechanism of immune evasion?
64. HBV HBx protein activates transcription factor NF-κB by acting on multiple cytoplasmic inhibitors of rel-related proteins
65. Molecular cloning and expression of the Fas ligand, a novel member of the tumor necrosis factor family
66. p53-independent apoptotic effects of the hepatitis B virus HBx protein in vivo and in vitro
67. The hepatitis B virus
68. Direct interaction of the HBV HBx protein with p53 response element-directed transactivation
69. Suppression of TNF-α-induced apoptosis by NF-κB
70. HBxAg in HBV carrier patients with liver cancer
71. HBxAg in liver from carrier patients with chronic hepatitis and cirrhosis
72. Abrogation of p53-induced apoptosis by the HBV X gene
73. TNF-α and cancer therapy-induced apoptosis: Potentiation by inhibition of NF-κB
74. The cDNA structure, expression, chromosomal assignment of the mouse Fas antigen
75. Direct association and nuclear import of the hepatitis B virus X protein with the NF-κB inhibitor IκBα
76. A transactivating function encoded in the hepatitis B virus X gene is conserved in the integrated state
77. The HBV X-ORF encodes a transactivator: A potential factor in viral hepatocarcinogenesis
78. Rel blocks both anti-Fas-and TNF alpha-induced apoptosis and an intact Rel transactivation domain is essential for this effect